A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, which is mainly caused by the imbalance of immune cells. Current treatment regimens predominately rely on corticosteroids and immunosuppressive agents, accompanied by various side effects. Interleukin-2 (IL-2) is deemed an importan...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Medicine |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1552473/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|